Further, overexpression of AKT1 in prostate cancers upregulates CXCR4 expression and loss of PTEN in the cells enhances AKT-mediated expression of CXCL12 and CXCR4 [66]. The gene discussed is AKT1; the disease is prostate carcinoma.